Therapeutic Medical Guidewire Market Research Report - Global Forecast till 2027

Global Therapeutic Medical Guidewire Market: Information by Type (Solid Guidewire and Wrapped Guidewire), Shape (J-Shape, Angled and Straight), Application (Peripheral Artery Disease, Cardiovascular Diseases, Neurovascular Diseases and Urological Disease) End User (Hospitals, Clinics and Academic Institutes) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2027

ID: MRFR/MED/3464-CR | July 2019 | Region: Global | 114 pages

Please note that the assessment period of report has been updated from 2016-2023 to 2020-2027. Cordially fill the sample form for updated data.

The Global Therapeutic Medical Guidewire Market is expected to register a CAGR of 5.9%and is anticipated to reach USD 3229.2 Million by 2023. Guidewires are the medical devices used in surgical procedures such as interventional cardiology, interventional radiology, gastroenterology, vascular surgery, and many others. They are made up of stainless-steel metallic structures that are used to guide the catheter for placement. Majorly, there are two types of guide wires, i.e., solid guidewire and wrapped guidewire. Both types have one end rigid and other-end flexible. The most commonly used are the straight tip, J-shaped tip, and angled guide wires. Multiple successful cases of biliary cannulation have been observed using a J-shaped tip guidewire.


The rising prevalence of chronic disorders, growing preference towards minimally invasive surgical procedures, and technological advancements in medical guide wire are the major drivers propelling market growth. However, the lack of skilled physicians and guide wires associated problems may hinder the growth of the market.


Market Dynamics


The burden of chronic disorders, such as cardiovascular diseases, chronic kidney diseases, and cancer is increasing globally. According to the report published in the Centers for Disease Control and Prevention (CDC) in 2017, nearly 92.1 million adults dealing with at least one type of cardiovascular disease. The rising prevalence of chronic disorders has increased demand for therapeutic guidewires. Thus, the rise in cases of chronic disorders strongly promotes the growth of the market. Additionally, growing preference towards minimally invasive surgical procedures and technological advancements in medical guide wire is likely to support market growth. On the other hand, lack of skilled physicians and guide wires associated problems is anticipated to hamper the market growth.


Global Therapeutic Medical Guidewire Market Size, by End User, 2016 (USD Million)  Therapeutic Medical Guidewire Market


Source: MRFR Analysis


Segmentation


The global therapeutic medical guidewire market has been segmented into age type, shape, application, and end user. By type, the market has been segmented into solid guidewire and wrapped guidewire. The global therapeutic medical guidewire market, by shape, has been segmented into J-shape, angled, and straight. By application, the market has been segmented into peripheral artery disease, cardiovascular diseases, neurovascular diseases, and urological diseases. By end-user, the market has been segmented into hospitals, clinics, and academic institutes. The hospitals segment accounted for a market value of USD 949.1 million in 2016.   


Key Players


The prominent players in the global therapeutic medical guidewire market are Cardinal Health (US), Biotronik (Germany), SP Medical AS (Denmark), Infiniti Medical (US), Acme Monaco (US), Abbott (US), Boston Scientific Corporation (US), Medtronic (Ireland), Terumo Medical Corporation (Japan), Cook Medical (US), and Impax Laboratories (US).


Some of the key strategies followed by the players operating in the global therapeutic medical guidewire market were innovation, product development, acquisition, and expansion.


Asia-Pacific Therapeutic Medical Guidewire Market Share, by Country, 2016 (%)  Therapeutic Medical Guidewire Market


Source: MRFR Analysis


Regional Analysis


The global therapeutic medical guidewire market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is estimated to dominate the global therapeutic medical guidewire market during the forecast period. This is attributed to the rising burden of chronic diseases, technological advancements, increasing preference towards the minimally invasive procedure, and escalating healthcare expenditure. Centers for Disease Control and Prevention (CDC) has stated that out of total annual healthcare expenditure, 86% is for people with chronic health conditions in the US. The European therapeutic medical guidewire market for is expected to be the second-largest during the forecast period. Increasing government support for research & development, and rising healthcare expenditure have driven the European therapeutic guidewire market.     


Asia-Pacific is the fastest-growing therapeutic guide wire market due to the rapidly changing healthcare sector, and the presence of enormous opportunities for the development of this market. Moreover, in the Asia-Pacific region, South Korea accounted for a market share of 13.3% in 2016. The Middle East & Africa has the least share in the market owing to the presence of poor and slow developing countries, especially, in the African region. The Middle East holds the significant share of the regional market due to well-developed technology and high spending.


Key Updates



  • In July 2017, Cardinal Health acquired Medtronic's Patient Care, Deep Vein Thrombosis, and Nutritional Insufficiency business for USD 6.1 billion.



  • In September 2017, Medtronic PLC launched StealthStation (TM) ENT, a surgical navigation system designed for surgeons treating conditions within the ear, nose, and throat (ENT) anatomy.


Global Therapeutic Medical Guidewire Market, by Type



  • Solid Guidewire

  • Wrapped guidewire


Global Therapeutic Medical Guidewire Market, by Shape



  • J-Shape

  • Angled

  • Straight


Global Therapeutic Medical Guidewire Market, by Application



  • Peripheral Artery Disease

  • Cardiovascular Diseases

  • Neurovascular Diseases

  • Urological Disease


Global Therapeutic Medical Guidewire Market, by End User



  • Hospitals

  • Clinics

  • Academic Institutes


Global Therapeutic Medical Guidewire Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • Latin America





  • Europe

    • Western Europe

      • Germany

      • UK

      • France

      • Italy

      • Spain

      • Rest of Western Europe



    • Eastern Europe





  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific





  • Middle East & Africa

    • UAE

    • Saudi Arabia

    • Oman

    • Kuwait

    • Qatar

    • Rest of Middle East & Africa




Intended Audience



  • Medical research laboratories

  • Research and development (R&D) companies

  • Market research and consulting service providers

  • Potential investors



1 Report Prologue

2 Market Introduction

2.1 Research Objective 16

2.2 Assumptions & Limitations 17

2.2.1 Assumptions 17

2.2.2 Limitations 17

3 Research Methodology

3.1 Research Process 18

3.2 Primary Research 19

3.3 Secondary Research 19

3.4 Market Size Estimation 20

4 Market Dynamics

4.1 Introduction 21

4.2 Drivers 22

4.2.1 Growing Prevalence Of Chronic Disorders (Impact Weightage: 40%) 22

4.2.2 Growing Preference Towards Minimally Invasive Surgical Procedures (Impact Weightage: 35%) 23

4.2.3 Technological Advancements In Medical Guidewire (Impact Weightage: 25%) 24

4.3 Restrains 25

4.3.1 Lack Of Skilled Physicians (Impact Weightage: 60%) 25

4.3.2 Guide Wires Associated Problems (Impact Weightage: 40%) 26

4.4 Opportunities 27

4.4.1 Guide Wire Assisted Surgery In Elderly Population 27

4.4.2 Macroeconomic Indicators 27

5 Market Factor Analysis

5.1 Porter’s Five Forces Model 29

5.1.1 Bargaining Power Of Suppliers 30

5.1.2 Bargaining Power Of Buyers 30

5.1.3 Threat Of New Entrants 30

5.1.4 Threat Of Substitutes 31

5.1.5 Intensity Of Rivalry 31

5.2 Value Chain Analysis 31

5.2.1 Raw Material 32

5.2.2 Supplier 33

5.2.3 Manufacturer 34

5.2.4 Distributer 35

5.2.5 Customer 35

5.2.6 Consumer 36

5.3 Demand & Supply: Gap Analysis 37

5.4 Pricing Analysis 37

6 Global Therapeutic Medical Guidewire By Type

6.1 Introduction 38

6.2 Solid Guidewire 39

6.3 Wrapped Guidewire 40

7 Global Therapeutic Medical Guidewire By Shape

7.1 Introduction 41

7.2 J-Shape 42

7.3 Angled 43

7.4 Straight 43

8 Global Therapeutic Medical Guidewire By Application

8.1 Introduction 44

8.2 Peripheral Artery Disease 45

8.3 Cardiovascular Diseases 46

8.4 Neurovascular Diseases 46

8.5 Urological Disease 47

9 Global Therapeutic Medical Guidewire By End Users

9.1 Introduction 48

9.2 Hospitals 49

9.3 Clinics 50

9.4 Academic Institutes 50

10 Global Therapeutic Medical Guidewire By Regions

10.1 Introduction 51

10.2 Americas 53

10.2.1 North America 55

10.2.1.1 US 57

10.2.1.2 Canada 58

10.2.2 South America 60

10.3 Europe 62

10.3.1 Western Europe 64

10.3.1.1 Germany 66

10.3.1.2 France 67

10.3.1.3 Italy 69

10.3.1.4 Spain 70

10.3.1.5 UK 72

10.3.1.6 Rest Of Western Europe 73

10.3.2 Eastern Europe 75

10.4 Asia-Pacific 77

10.4.1 China 79

10.4.2 India 81

10.4.3 Japan 82

10.4.4 South Korea 84

10.4.5 Australia 85

10.4.6 Rest Of Asia-Pacific 87

10.5 Middle East & Africa 89

10.5.1 UAE 92

10.5.2 Saudi Arabia 93

10.5.3 Oman 95

10.5.4 Kuwait 96

10.5.5 Qatar 98

10.5.6 Rest Of Middle East & Africa 99

11 Competitive Landscape

11.1 Introduction 101

12 Company Profiles

12.1 Cordis (Cardinal Health) 102

12.1.1 Company Overview 102

12.1.2 Financials 102

12.1.3 Products 102

12.1.4 Strategy 102

12.1.5 Key Developments 102

12.2 Biotronik 103

12.2.1 Company Overview 103

12.2.2 Financials 103

12.2.3 Products 103

12.2.4 Strategy 103

12.2.5 Key Developments 103

12.3 SP Medical AS 104

12.3.1 Company Overview 104

12.3.2 Financials 104

12.3.3 Products 104

12.3.4 Strategy 104

12.3.5 Key Developments 104

12.4 Infiniti Medical 105

12.4.1 Company Overview 105

12.4.2 Financials 105

12.4.3 Products 105

12.4.4 Strategy 105

12.4.5 Key Developments 105

12.5 Acme Monaco 106

12.5.1 Company Overview 106

12.5.2 Financials 106

12.5.3 Products 106

12.5.4 Strategy 106

12.5.5 Key Developments 106

12.6 Abbott 107

12.6.1 Company Overview 107

12.6.2 Financials 107

12.6.3 Products 107

12.6.4 Strategy 107

12.6.5 Key Developments 107

12.7 Boston Scientific Corporation 108

12.7.1 Company Overview 108

12.7.2 Financials 108

12.7.3 Products 108

12.7.4 Strategy 108

12.7.5 Key Developments 108

12.8 Medtronic 109

12.8.1 Company Overview 109

12.8.2 Financials 109

12.8.3 Products 109

12.8.4 Strategy 109

12.8.5 Key Developments 109

12.9 Terumo Medical Corporation 110

12.9.1 Company Overview 110

12.9.2 Financials 110

12.9.3 Products 110

12.9.4 Strategy 110

12.9.5 Key Developments 110

12.10 Cook Medical 111

12.10.1 Company Overview 111

12.10.2 Financials 111

12.10.3 Products 111

12.10.4 Strategy 111

12.10.5 Key Developments 111

13 MRFR Conclusion

13.1 Key Findings 112

13.1.1 From CEO’s View Point 112

13.2 Key Companies To Watch 112

14 Appendix

14.1 Discussion Blue Print 113

15 List Of Tables

TABLE 1 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE BY TYPE USD MILLION 2020–2027 38

TABLE 2 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE MARKET FOR SOLID GUIDEWIRE USD MILLION 2020–2027 39

TABLE 3 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE MARKET FOR WRAPPED GUIDEWIRE USD MILLION 2020–2027 40

TABLE 4 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPE USD MILLION 2020–2027 41

TABLE 5 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE MARKET FOR J–SHAPE USD MILLION 2020–2027 42

TABLE 6 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE MARKET FOR ANGLED USD MILLION 2020–2027 43

TABLE 7 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE MARKET FOR STRAIGHT USD MILLION 2020–2027 43

TABLE 8 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATION USD MILLION 2020–2027 44

TABLE 9 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE MARKET FOR PERIPHERAL ARTERY DISEASE USD MILLION 2020–2027 45

TABLE 10 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE MARKET FOR CARDIOVASCULAR DISEASES USD MILLION 2020–2027 46

TABLE 11 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE MARKET FOR NEUROVASCULAR DISEASES USD MILLION 2020–2027 46

TABLE 12 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE MARKET FOR UROLOGICAL DISEASE USD MILLION 2020–2027 47

TABLE 13 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2020–2027 48

TABLE 14 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE MARKET FOR HOSPITALS USD MILLION 2020–2027 49

TABLE 15 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE MARKET FOR CLINICS USD MILLION 2020–2027 50

TABLE 16 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE MARKET FOR ACADEMIC INSTITUTES USD MILLION 2020–2027 50

TABLE 17 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE BY REGIONS USD MILLION 2020–2027 51

TABLE 18 AMERICAS THERAPEUTIC MEDICAL GUIDEWIRE BY REGIONS USD MILLION 2020–2027 53

TABLE 19 AMERICAS THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2020–2027 54

TABLE 20 AMERICAS THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2020–2027 54

TABLE 21 AMERICAS THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2020–2027 54

TABLE 22 AMERICAS THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2020–2027 55

TABLE 23 NORTH AMERICA THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2020–2027 55

TABLE 24 NORTH AMERICA THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2020–2027 55

TABLE 25 NORTH AMERICA THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2020–2027 56

TABLE 26 NORTH AMERICA THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2020–2027 56

TABLE 27 US THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2020–2027 57

TABLE 28 US THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2020–2027 57

TABLE 29 US THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2020–2027 57

TABLE 30 US THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2020–2027 58

TABLE 31 CANADA THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2020–2027 58

TABLE 32 CANADA THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2020–2027 58

TABLE 33 CANADA THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2020–2027 59

TABLE 34 CANADA THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2020–2027 59

TABLE 35 SOUTH AMERICA THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2020–2027 60

TABLE 36 SOUTH AMERICA THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2020–2027 60

TABLE 37 SOUTH AMERICA THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2020–2027 61

TABLE 38 SOUTH AMERICA THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2020–2027 61

TABLE 39 EUROPE THERAPEUTIC MEDICAL GUIDEWIRE BY REGIONS USD MILLION 2020–2027 62

TABLE 40 EUROPE THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2020–2027 63

TABLE 41 EUROPE THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2020–2027 63

TABLE 42 EUROPE THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2020–2027 63

TABLE 43 EUROPE THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2020–2027 64

TABLE 44 WESTERN EUROPE THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2020–2027 64

TABLE 45 WESTERN EUROPE THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2020–2027 64

TABLE 46 WESTERN EUROPE THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2020–2027 65

TABLE 47 WESTERN EUROPE THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2020–2027 65

TABLE 48 GERMANY THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2020–2027 66

TABLE 49 GERMANY THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2020–2027 66

TABLE 50 GERMANY THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2020–2027 66

TABLE 51 GERMANY THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2020–2027 67

TABLE 52 FRANCE THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2020–2027 67

TABLE 53 FRANCE THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2020–2027 67

TABLE 54 FRANCE THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2020–2027 68

TABLE 55 FRANCE THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2020–2027 68

TABLE 56 ITALY THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2020–2027 69

TABLE 57 ITALY THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2020–2027 69

TABLE 58 ITALY THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2020–2027 69

TABLE 59 ITALY THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2020–2027 70

TABLE 60 SPAIN THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2020–2027 70

TABLE 61 SPAIN THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2020–2027 70

TABLE 62 SPAIN THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2020–2027 71

TABLE 63 SPAIN THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2020–2027 71

TABLE 64 UK THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2020–2027 72

TABLE 65 UK THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2020–2027 72

TABLE 66 UK THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2020–2027 72

TABLE 67 UK THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2020–2027 73

TABLE 68 REST OF WESTERN EUROPE THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2020–2027 73

TABLE 69 REST OF WESTERN EUROPE THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2020–2027 73

TABLE 70 REST OF WESTERN EUROPE THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2020–2027 74

TABLE 71 REST OF WESTERN EUROPE THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2020–2027 74

TABLE 72 EASTERN EUROPE THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2020–2027 75

TABLE 73 EASTERN EUROPE THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2020–2027 75

TABLE 74 EASTERN EUROPE THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2020–2027 76

TABLE 75 EASTERN EUROPE THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2020–2027 76

TABLE 76 ASIA-PACIFIC THERAPEUTIC MEDICAL GUIDEWIRE BY REGIONS USD MILLION 2020–2027 77

TABLE 77 ASIA-PACIFIC THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2020–2027 78

TABLE 78 ASIA-PACIFIC THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2020–2027 78

TABLE 79 ASIA-PACIFIC THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2020–2027 78

TABLE 80 ASIA-PACIFIC THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2020–2027 79

TABLE 81 CHINA THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2020–2027 79

TABLE 82 CHINA THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2020–2027 79

TABLE 83 CHINA THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2020–2027 80

TABLE 84 CHINA THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2020–2027 80

TABLE 85 INDIA THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2020–2027 81

TABLE 86 INDIA THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2020–2027 81

TABLE 87 INDIA THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2020–2027 81

TABLE 88 INDIA THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2020–2027 82

TABLE 89 JAPAN THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2020–2027 82

TABLE 90 JAPAN THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2020–2027 82

TABLE 91 JAPAN THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2020–2027 83

TABLE 92 JAPAN THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2020–2027 83

TABLE 93 SOUTH KOREA THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2020–2027 84

TABLE 94 SOUTH KOREA THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2020–2027 84

TABLE 95 SOUTH KOREA THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2020–2027 84

TABLE 96 SOUTH KOREA THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2020–2027 85

TABLE 97 AUSTRALIA THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2020–2027 85

TABLE 98 AUSTRALIA THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2020–2027 85

TABLE 99 AUSTRALIA THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2020–2027 86

TABLE 100 AUSTRALIA THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2020–2027 86

TABLE 101 REST OF ASIA-PACIFIC THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2020–2027 87

TABLE 102 REST OF ASIA-PACIFIC THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2020–2027 87

TABLE 103 REST OF ASIA-PACIFIC THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2020–2027 88

TABLE 104 REST OF ASIA-PACIFIC THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2020–2027 88

TABLE 105 MIDDLE EAST & AFRICA THERAPEUTIC MEDICAL GUIDEWIRE BY REGIONS USD MILLION 2020–2027 89

TABLE 106 MIDDLE EAST & AFRICA THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2020–2027 90

TABLE 107 MIDDLE EAST & AFRICA THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2020–2027 90

TABLE 108 MIDDLE EAST & AFRICA THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2020–2027 91

TABLE 109 MIDDLE EAST & AFRICA THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2020–2027 91

TABLE 110 UAE THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2020–2027 92

TABLE 111 UAE THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2020–2027 92

TABLE 112 UAE THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2020–2027 92

TABLE 113 UAE THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2020–2027 93

TABLE 114 SAUDI ARABIA THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2020–2027 93

TABLE 115 SAUDI ARABIA THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2020–2027 93

TABLE 116 SAUDI ARABIA THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2020–2027 94

TABLE 117 SAUDI ARABIA THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2020–2027 94

TABLE 118 OMAN THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2020–2027 95

TABLE 119 OMAN THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2020–2027 95

TABLE 120 OMAN THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2020–2027 95

TABLE 121 OMAN THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2020–2027 96

TABLE 122 KUWAIT THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2020–2027 96

TABLE 123 KUWAIT THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2020–2027 96

TABLE 124 KUWAIT THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2020–2027 97

TABLE 125 KUWAIT THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2020–2027 97

TABLE 126 QATAR THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2020–2027 98

TABLE 127 QATAR THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2020–2027 98

TABLE 128 QATAR THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2020–2027 98

TABLE 129 QATAR THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2020–2027 99

TABLE 130 REST OF MIDDLE EAST & AFRICA THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2020–2027 99

TABLE 131 REST OF MIDDLE EAST & AFRICA THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2020–2027 99

TABLE 132 REST OF MIDDLE EAST & AFRICA THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2020–2027 100

TABLE 133 REST OF MIDDLE EAST & AFRICA THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2020–2027 100

16 List Of Figures

FIGURE 1 GLOBAL THERAPEUTIC MEDICAL GUIDE WIRE MARKET SHARE BY TYPE 2020 (%) 14

FIGURE 2 GLOBAL THERAPEUTIC MEDICAL GUIDE WIRE MARKET SHARE BY APPLICATION 2020 (%) 14

FIGURE 3 GLOBAL THERAPEUTIC MEDICAL GUIDE WIRE MARKET SHARE BY SHAPE 2020 (%) 15

FIGURE 4 MARKET STRUCTURE 17

FIGURE 5 RESEARCH PROCESS 18

FIGURE 6 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE BY TYPE USD MILLION 2020 & 2027 39

FIGURE 7 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPE USD MILLION 2020–2027 42

FIGURE 8 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATION USD MILLION 2020 & 2027 45

FIGURE 9 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2020 & 2027 49

FIGURE 10 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE BY REGIONS USD MILLION 2020 & 2027 52

FIGURE 11 AMERICAS THERAPEUTIC MEDICAL GUIDEWIRE BY REGIONS MARKET SHARE 2020 (%) 53

FIGURE 12 EUROPE THERAPEUTIC MEDICAL GUIDEWIRE BY REGIONS MARKET SHARE 2020 (%) 62

FIGURE 13 ASIA-PACIFIC THERAPEUTIC MEDICAL GUIDEWIRE BY REGIONS MARKET SHARE 2020 (%) 77

FIGURE 14 MIDDLE EAST & AFRICA THERAPEUTIC MEDICAL GUIDEWIRE BY REGIONS USD MILLION 2020 & 2027 89

FIGURE 15 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE COMPANY SHARE ANALYSIS 2020 (%) 101